These novel medications , Semaglutide , represent a groundbreaking advancement in addressing type 2 diabetes and conceivably associated ailments . They are classified as GLP-1 hormone activators , https://nanniezcni972608.wssblogs.com/41360431/semaglutide-a-comprehensive-examination-into-incretin-compounds